The impact of realistic age structure in simple models of tuberculosis transmission

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Brooks Pollock, Ellen ^a   Cohen, Ted ^a,b   Murray, Megan ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE CONTROL; DISEASE TRANSMISSION; HUMAN; LIFESPAN; MATHEMATICAL MODEL; MORTALITY; PREVALENCE; SURVIVAL; TUBERCULOSIS; THEORETICAL MODEL;

HUMANS; MODELS, THEORETICAL; PREVALENCE; TUBERCULOSIS;

EID: 77649104571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008479     Document Type: Article

References (38)

1. Waaler H, Piot M (1969) The use of an epidemiological model for estimating the effectiveness of tuberculosis control measures. Bulletin of the World Health Organization 41: 75-93.
2. Blower SM, McLean AR, Porco TC, Small PM, Hopewell PC, et al. (1995) The intrinsic transmission dynamics of tuberculosis epidemics. Nature Medicine 1: 815-21.
3. Vynnycky E, Fine PE (1997) The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901. International Journal of Tuberculosis and Lung Disease 1: 389-96.
4. Dye C, Garnett GP, Sleeman K, Williams BG (1998) Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 352: 1886-91.
5. Murray C, Salomon J (1998) Modeling the impact of global tuberculosis control strategies. Proceedings of the National Academy of Sciences 95: 13881-13886.
6. Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant m. tuberculosis of heterogeneous fitness. Nature Medicine 10: 1117-1121.
7. Dye C, Williams B (2000) Criteria for the control of drug-resistant tuberculosis. Proceedings of the National Academy of Sciences 97: 8180-8185.
8. Dye C, Williams BG (2008) Eliminating human tuberculosis in the twenty-first century. Journal of the Royal Society, Interface 5: 653-62.
9. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine 163: 1009-1021.
10. Shah N, Wright A, Bai G, Barrera L, Boulahbal F, et al. (2007) Worldwide emergence of extensively drug-resistant tuberculosis. Emerging Infectious Diseases 13: 380.
11. Williams BG, Dye C (2003) Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301: 1535-7.
12. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, et al. (2005) Tuberculosis control in the era of HIV. Nature Reviews Immunology 5: 819-826.
13. Basu S, Galvani AP (2009) The evolution of tuberculosis virulence. Bull Math Biol. pp 1-16.
14. Bloom B, Murray C (1992) Tuberculosis: commentary on a reemergent killer. Science 257: 1055-1064.
15. Stewart GR, Robertson BD, Young DB (2003) Tuberculosis: a problem with persistence. Nature Reviews Microbiology 1: 97-105.
16. Anderson R, May R (1991) Infectious Diseases of Humans Oxford Science Publications.
17. Castillo-Chavez C, Song B (2004) Dynamical models of tuberculosis and their applications. Mathematical Biosciences and Engineering 1: 361-404.
18. Keyfitz N, Caswell H (2005) Applied Mathematical Demography Springer.
19. Hethcote H (2000) The mathematics of infectious diseases. SIAM REVIEW 42: 599-653.
20. Keeling MJ, Grenfell BT (1998) Effect of variability in infection period on the persistence and spatial spread of infectious diseases. Mathematical Biosciences 147: 207-226.
21. Lloyd A (2001) Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics. Theoretical Population Biology 60: 59-71.
22. Williams JR, Manfredi P (2004) Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. International Journal of Epidemiology 33: 566-572.
23. Cummings D, Iamsirithaworn I, Lessler JT, McDermott A, Prasanthong R, et al. (2009) The impact of the demographic transition on dengue in Thailand: Insights from a statistical analysis and mathematical modeling. PLoS Medicine 6: e1000139.
24. Gompertz B (1825) On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philosophical Transactions of the Royal Society of London 115: 513-583.
25. Anderson RM, May RM (1983) Vaccination against rubella and measles: quantitative investigations of different policies. Journal of Hygiene 90: 259-325.
26. Vynnycky E, Fine PE (1998) The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers. Epidemiology and Infection 121: 309-24.
27. Vynnycky E, Fine P (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. American Journal of Epidemiology 152: 247-263.
28. Human Mortality Database (accessed 15/07/2009) University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). URL www.mortality.org.
29. World Health Organization (2009) Global tuberculosis control: Epidemiology, strategy, financing. WHO Report.
30. May R, Anderson RM (1985) Endemic infections in growing populations. Mathematical Biosciences 77: 141-156.
31. Promislow DEL, Tatar M, Pletcher S, Carey JR (1999) Below-threshold mortality: implications for studies in evolution, ecology and demography. Journal of Evolutionary Biology 12: 314-328.
32. Vynnycky E, Fine PE (1997) The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiology and Infection 119: 183-201.
33. Lloyd A (2001) Destabilization of epidemic models with the inclusion of realistic distributions of infectious periods. Proceedings of the Royal Society B 268: 985-993.
34. Heffernan J, Smith RJ, Wahl LM (2005) Perspectives on the basic reproductive ratio. Journal of The Royal Society Interface 2: 281-293.
35. Salomon JA, Lloyd-Smith JO, Getz WM, Resch S, Sánchez MS, et al. (2006) Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Medicine 3: e273.
36. Vynnycky E, Borgdorff MW, Leung CC, Tam CM, Fine PEM (2008) Limited impact of tuberculosis control in hong kong: attributable to high risks of reactivation disease. Epidemiology and Infection 136: 943-952.
37. Hughes G, Currie C, Corbett EL (2006) Modeling tuberculosis in areas of high HIV prevalence. Proceedings of the 38th conference on Winter simulation. pp 459-465.
38. Anderson RM, May R, McLean AR (1988) Possible demographic consequences of AIDS in developing countries. Nature 322: 228-234.